These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8632823)

  • 1. Role of the thrombin receptor in development and evidence for a second receptor.
    Connolly AJ; Ishihara H; Kahn ML; Farese RV; Coughlin SR
    Nature; 1996 Jun; 381(6582):516-9. PubMed ID: 8632823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for thrombin receptor signaling in endothelial cells during embryonic development.
    Griffin CT; Srinivasan Y; Zheng YW; Huang W; Coughlin SR
    Science; 2001 Aug; 293(5535):1666-70. PubMed ID: 11533492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor 3 is a second thrombin receptor in humans.
    Ishihara H; Connolly AJ; Zeng D; Kahn ML; Zheng YW; Timmons C; Tram T; Coughlin SR
    Nature; 1997 Apr; 386(6624):502-6. PubMed ID: 9087410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual thrombin receptor system for platelet activation.
    Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
    Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice.
    Major CD; Santulli RJ; Derian CK; Andrade-Gordon P
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):931-9. PubMed ID: 12676802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptors in vascular biology.
    Coughlin SR
    Thromb Haemost; 2001 Jul; 86(1):298-307. PubMed ID: 11487018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V.
    Cui J; O'Shea KS; Purkayastha A; Saunders TL; Ginsburg D
    Nature; 1996 Nov; 384(6604):66-8. PubMed ID: 8900278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
    Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKCtheta is required for hemostasis and positive regulation of thrombin-induced platelet aggregation and alpha-granule secretion.
    Cohen S; Braiman A; Shubinsky G; Ohayon A; Altman A; Isakov N
    Biochem Biophys Res Commun; 2009 Jul; 385(1):22-7. PubMed ID: 19433059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues in the development of thrombin receptor antagonists.
    Brass LF
    Thromb Haemost; 1995 Jul; 74(1):499-505. PubMed ID: 8578513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of protease-activated receptor-2 during embryonic development.
    Jenkins AL; Chinni C; De Niese MR; Blackhart B; Mackie EJ
    Dev Dyn; 2000 Jul; 218(3):465-71. PubMed ID: 10878611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development.
    Soifer SJ; Peters KG; O'Keefe J; Coughlin SR
    Am J Pathol; 1994 Jan; 144(1):60-9. PubMed ID: 8291612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin and vascular development: a sticky subject.
    Moser M; Patterson C
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):922-30. PubMed ID: 12807713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated G protein-coupled receptors on human platelets and endothelial cells.
    Brass LF; Molino M
    Thromb Haemost; 1997 Jul; 78(1):234-41. PubMed ID: 9198159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissection of protease-activated receptor-1-dependent and -independent responses to thrombin in skeletal myoblasts.
    de Niese MR; Chinni C; Pike RN; Bottomley SP; Mackie EJ
    Exp Cell Res; 2002 Mar; 274(1):149-56. PubMed ID: 11855866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of thrombin receptors in rat brain capillary endothelial cells.
    Bartha K; Dömötör E; Lanza F; Adam-Vizi V; Machovich R
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):175-82. PubMed ID: 10616806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.